- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04202120
Age Stereotype Priming and Social Participation (ASPSP)
Age Stereotype Priming and Moderating Effects of Social Participation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
All participants are community-dwelling older adults residing in Hong Kong. They are invited to review their social participation profile and given a brief psycho-education about memory.
They are then randomly allocated to one of the two following conditions. Participants are primed either with age stereotypes or non-age stereotypes words by implicit priming intervention in the context of a reaction task prior to the episodic memory tasks. Other measures such as demographic variables and social participation rate are collected by questionnaire during the delayed recall interval.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alma Au, PhD
- Phone Number: +85293609492
- Email: ssalma@polyu.edu.hk
Study Contact Backup
- Name: Stephen Chan, Masters
- Phone Number: +85227667746
- Email: sccy.chan@connect.polyu.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Applied Social Sciences, Hong Kong Polytechnic University
-
Contact:
- Alma Au, PhD
- Phone Number: 85227665504
- Email: ssalma@polyu.edu.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Indication of largely normal cognitive functioning as screened on the Montreal Cognitive Assessment (MoCA) with Hong Kong norms -
Exclusion Criteria:
Sensory deficits and evidence of cognitive impairment as screened on the Montreal Cognitive Assessment (MoCA) with Hong Kong norms
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Age-related priming
Participants received a review of the profile of their social participation.
They also received psycho-education about memory components.
They were give given memory tests with age-related primes.
|
The priming intervention was performed using the E-prime 2.0 software (Psychology Software Tools, Pittsburgh, PA).
To ensure the primes flashed on screen were beyond awareness, the similar adjustment procedure was taken (see Levy, 1996; Stein et al., 2002).
After the trial block, participants were asked to try to report any words viewed during each trial.
The stimulus onset asynchrony (SOA) will be reduced or enhanced whenever 2 words or above were correctly reported or no single word could be reported respectively.
The priming SOA for this study ranged from 32 ms to 208 ms (M = 98.70 ms.
SD = 48.60).
|
Active Comparator: Non-age related priming
Participants received a review of the profile of their social participation.
They also received psycho-education about memory components.
They were give given memory tests with NON age-related primes.
|
he priming intervention was performed using the E-prime 2.0 software (Psychology Software Tools, Pittsburgh, PA).
To ensure the primes flashed on screen were beyond awareness, the similar adjustment procedure was taken (see Levy, 1996; Stein et al., 2002).
After the trial block, participants were asked to try to report any words viewed during each trial.
The stimulus onset asynchrony (SOA) will be reduced or enhanced whenever 2 words or above were correctly reported or no single word could be reported respectively.
The priming SOA for this study ranged from 32 ms to 208 ms (M = 98.70 ms.
SD = 48.60).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hong Kong List Learning Test
Time Frame: Change from baseline through study completion, an average of 2 hours
|
The Hong Kong List Learning is a validated tool for assessing episodic memory for aged Chinese speaking adults (Chan, 2006).
It was further taken for investigating differences among older adults with normal cognitive ability and older adults with mild cognitive impairment (Yeung et al., 2016).
The random control list was taken in this study.
It comprises 16 words formed by four categories:
|
Change from baseline through study completion, an average of 2 hours
|
Collaborators and Investigators
Investigators
- Study Chair: Alma Au, PhD, Dr (female)
Publications and helpful links
General Publications
- Au A, Chan AS, Chiu H. Verbal learning in Alzheimer's dementia. J Int Neuropsychol Soc. 2003 Mar;9(3):363-75. doi: 10.1017/S1355617703930025.
- Wong A, Yiu S, Nasreddine Z, Leung KT, Lau A, Soo YOY, Wong LK, Mok V. Validity and reliability of two alternate versions of the Montreal Cognitive Assessment (Hong Kong version) for screening of Mild Neurocognitive Disorder. PLoS One. 2018 May 23;13(5):e0196344. doi: 10.1371/journal.pone.0196344. eCollection 2018.
- Stein R, Blanchard-Fields F, Hertzog C. The effects of age-stereotype priming on the memory performance of older adults. Exp Aging Res. 2002 Apr-Jun;28(2):169-81. doi: 10.1080/03610730252800184.
- Chan SCY, Au AML, Lai SMK. The detrimental impacts of negative age stereotypes on the episodic memory of older adults: does social participation moderate the effects? BMC Geriatr. 2020 Nov 5;20(1):452. doi: 10.1186/s12877-020-01833-z.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AFC2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Memory Loss
-
Memorial Sloan Kettering Cancer CenterCompletedMemory Losses | Amnesia-Memory LossUnited States
-
University of Texas Southwestern Medical CenterUCB PharmaCompletedMemory Loss Associated With Corticosteroid Use | Manic State Associated With Corticosteroid UseUnited States
-
Fundació Institut de Recerca de l'Hospital de la...CompletedAge-Related Memory Disorders | Memory LossSpain
-
Massachusetts General HospitalRecruitingHealthy Lifestyle | Risk Reduction Behavior | Memory Loss (Excluding Dementia)United States
-
New York State Psychiatric InstituteMars, Inc.Completed
-
Asan Medical CenterCompleted
-
John Wesson Ashford JrUS Department of Veterans AffairsActive, not recruiting
-
Rush University Medical CenterPamlab, Inc.CompletedSubjective Memory Loss in Older PersonsUnited States
-
University of UtahRecruiting
-
Northwestern UniversityCompleted
Clinical Trials on Age-related stereotyping priming
-
National University of SingaporeActive, not recruitingAnxiety | Educational Problems | Marriage Age | Childbearing, Delayed | Age Related Female InfertilitySingapore
-
Guardion Health Sciences, Inc.Western University of Health Sciences; Eye Clinic of AustinCompletedMacular Degeneration | Age-related Macular Degeneration | Retinal DrusenUnited States
-
Valme University HospitalHospital Universitario Virgen Macarena; Hospital Universitario Reina Sofia... and other collaboratorsCompletedHepatitis C, Chronic | Hepatitis B, Chronic | Human Immunodeficiency VirusSpain
-
Centre Oscar LambretUnknown
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruitingChronic Rhinosinusitis With Nasal PolypsItaly
-
Alvotech Swiss AGIqvia Pty LtdCompletedHealthy Adult SubjectsNew Zealand, United Kingdom
-
Novartis PharmaceuticalsCompletedNeovacular Age-related Macular DegenerationTaiwan, Thailand, Israel, Korea, Republic of, Philippines, Singapore, Malaysia
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Small Cell Lung Cancer | Prostate Cancer | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction Adenocarcinoma | Non-small Cell Lung Cancer, Squamous | Non-small Cell Lung Cancer, Non-squamousUnited States, Korea, Republic of, Italy, United Kingdom, Australia, Taiwan
-
Population Health Research InstituteCompletedHyperglycemia | Myocardial Infarction | Cardiovascular DiseasesArgentina, Canada, India